47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 0,7 | 0,5 | -24,2 |
Gross profit (loss) | 0,5 | 0,6 | 0,5 | -19,1 |
EBITDA | 0,5 | 0,6 | 0,6 | -5,6 |
Short time liabilities | 3,2 | 2,6 | 2,2 | -16,1 |
Other operating costs | 0 | 0,1 | 0,1 | 15,4 |
Equity capital | 1,6 | 0,7 | 0,9 | 36,6 |
Operating profit (EBIT) | 0,5 | 0,6 | 0,5 | -18,7 |
Assets | 4,9 | 3,3 | 3,1 | -5,5 |
Net profit (loss) | 0,5 | 0,6 | 0,5 | -19,1 |
Cash | 1 | 0,5 | 0,3 | -43,8 |
Net income from sale | 14,8 | 16,3 | 17,4 | 7 |
Liabilities and provisions for liabilities | 3,2 | 2,6 | 2,2 | -16,1 |
Working assets | 4,5 | 2,9 | 2,8 | -1,9 |
Other income costs | 0 | 0 | 0,1 | 592,6 |
Depreciation | 0 | 0 | 0,1 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 31,8 | 90,3 | 53,5 | -36,8 |
Equity capital to total assets | 33,7 | 20,2 | 29,2 | 9 |
Gross profit margin | 3,5 | 3,6 | 2,8 | -0,8 |
EBITDA Margin | 3,5 | 3,6 | 3,2 | -0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 80 | 58 | 46 | -12 |
Current financial liquidity indicator | 1.3975889682769775 | 1.1137480735778809 | 1.3019300699234009 | 0,2 |
Net dept to EBITDA | -1.8610694408416748 | -0.8773928284645081 | -0.5221486687660217 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane